Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy.
about
Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@en
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@nl
type
label
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@en
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@nl
prefLabel
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@en
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@nl
P2093
P1476
Discovery of 1-(4-((3-(4-methy ...... tment of diabetic nephropathy.
@en
P2093
Dejian Jiang
Lijian Tao
Miaomiao Lu
Xuan Xiong
Zeneng Cheng
Zhangzhe Peng
P304
P356
10.1016/J.BMCL.2017.07.001
P407
P50
P577
2017-07-04T00:00:00Z